Global Cord Blood Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Tina Zheng
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 15.3yrs |
| CEO ownership | n/a |
| Management average tenure | 15.3yrs |
| Board average tenure | 1.9yrs |
Recent management updates
Recent updates
Global Cord Blood GAAP EPS of $0.14, revenue of $46.88M
Jul 05Pounce On Global Cord For The Year Of The Tiger
Apr 29Global Cord Blood Corp. Looks Anemic On Slow Growth, Regulatory Concerns
Apr 08Global Cord Blood: With 6.0x P/E And 24% EPS CAGR, Subscriber Growth Continues
Dec 01Global Cord Blood Is An Undervalued Business With Accelerating Growth, Benefiting From China's Policy Changes
Jul 30Global Cord Blood: New China Policy Catalyst, 146% Net Cash And 24% EPS CAGR
Jul 01Global Cord Blood announces NHC policy update
Jan 05Global Cord Blood reports FQ2 results
Nov 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2022 | n/a | n/a | CN¥501m |
| Dec 31 2021 | n/a | n/a | CN¥524m |
| Sep 30 2021 | n/a | n/a | CN¥506m |
| Jun 30 2021 | n/a | n/a | CN¥512m |
| Mar 31 2021 | CN¥3m | CN¥3m | CN¥508m |
| Dec 31 2020 | n/a | n/a | CN¥478m |
| Sep 30 2020 | n/a | n/a | CN¥506m |
| Jun 30 2020 | n/a | n/a | CN¥495m |
| Mar 31 2020 | CN¥7m | CN¥4m | CN¥471m |
| Dec 31 2019 | n/a | n/a | CN¥465m |
| Sep 30 2019 | n/a | n/a | CN¥381m |
| Jun 30 2019 | n/a | n/a | CN¥326m |
| Mar 31 2019 | CN¥3m | CN¥3m | CN¥291m |
| Dec 31 2018 | n/a | n/a | CN¥231m |
| Sep 30 2018 | n/a | n/a | CN¥239m |
| Jun 30 2018 | n/a | n/a | CN¥242m |
| Mar 31 2018 | CN¥6m | CN¥3m | CN¥237m |
Compensation vs Market: Insufficient data to establish whether Tina's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Insufficient data to compare Tina's compensation with company performance.
CEO
Tina Zheng (51 yo)
15.3yrs
Tenure
CN¥3,385,565
Compensation
Ms. Ting Zheng, also known as Tina, serves as the Chief Executive Officer of Global Cord Blood Corporation (formerly known as China Cord Blood Corporation) since 2009 and also serves as Chief Executive Off...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & CEO of Beijing Division | 15.3yrs | CN¥3.39m | no data | |
| Chief Financial Officer | no data | CN¥3.39m | 0.34% CN¥ 567.0k | |
| Chief Technology Officer | 20.3yrs | CN¥804.48k | no data | |
| Chief Executive Officer of Guangdong & Zhejiang Divisions | 15.3yrs | CN¥1.69m | no data | |
| Vice President of Corporate Finance | no data | no data | no data |
15.3yrs
Average Tenure
57.5yo
Average Age
Experienced Management: CORB.F's management team is seasoned and experienced (15.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director | less than a year | no data | no data | |
| Director | 1.9yrs | no data | no data | |
| Director | 1.9yrs | no data | no data | |
| Director | 1.9yrs | no data | no data | |
| Director | 1.9yrs | no data | no data | |
| Director | 1.9yrs | no data | no data | |
| Director | 1.3yrs | no data | no data | |
| Director | 1.3yrs | no data | no data | |
| Director | 1.3yrs | no data | no data |
1.9yrs
Average Tenure
Experienced Board: CORB.F's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.